Columbus Circle Investors’s Kite Pharma, Inc. KITE Stock Holding History

Columbus Circle Investors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-77,600	Closed	-$4.33M	–	333
2016 Q3	$4.33M	Buy	77,600 +60,734	+360%	+$3.38M	0.05%	212
2016 Q2	$843K	Buy	+16,866	New	+$829K	0.01%	236
2015 Q2	–	Sell	-101,987	Closed	-$5.88M	–	329
2015 Q1	$5.88M	Buy	101,987 +95,877	+1,569%	+$6.43M	0.04%	236
2014 Q4	$352K	Buy	+6,110	New	+$257K	﹤0.01%	282

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Columbus Circle Investors's KITE Position: Q4 2016 in Review

Columbus Circle Investors sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 77,600 shares — an estimated $4.33M sold.

Columbus Circle Investors first reported a position in KITE in Q4 2014 and held it in 4 quarters. The position peaked at $5.88M in Q1 2015. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

Columbus Circle Investors reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
Columbus Circle Investors sold 77,600 Kite Pharma, Inc. shares in Q4 2016, an estimated $4.33M.
Columbus Circle Investors first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 4 quarters.
Columbus Circle Investors's Kite Pharma, Inc. position peaked at $5.88M in Q1 2015.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on Columbus Circle Investors's 13F filing for Q4 2016, filed 2 Feb 2017.